TABLE 3.

Potential safety signals related to pregnancies, foetuses and neonates found for remdesivir. FAERS (2020–2022).

SOC a	Signal	Frequency of drug-event pair	ROR b (95%CI)
Pregnancy, Puerperium and Perinatal Conditions	Abortion	3	5.2 (1.7–16.1)
	Foetal death	7	6.3 (3.0–13.3)
	Premature delivery	11	2.0 (1.1–3.6)
	Premature labor	4	4.2 (1.6–11.1)
Injury, Poisoning and Procedural Complications	Maternal drugs affecting foetus	3	10.8 (3.4–33.7)
	Maternal exposure during pregnancy	70	2.3 (1.8–2.9)

^a System Organ Class.

^b Reporting Odds Ratio.